Page last updated: 2024-11-08

phyllanthin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID358901
CHEMBL ID1253999
CHEBI ID8177
MeSH IDM0507696

Synonyms (31)

Synonym
NSC619043 ,
nsc-619043
NCI60_005684 ,
phyllanthin
10351-88-9
AC1L7DK7 ,
4-[(2s,3s)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-1,2-dimethoxybenzene
CHEMBL1253999
75o1tff47z ,
benzene, 1,1'-(2,3-bis(methoxymethyl)-1,4-butanediyl)bis(3,4-dimethoxy-, (s-(r*,r*))-
nsc 619043
unii-75o1tff47z
butane, 1,4-dimethoxy-2,3-diveratryl-, (2s,3s)-(+)-
phyllanthin (constituent of phyllanthus amarus) [dsc]
benzene, 1,1'-((2s,3s)-2,3-bis(methoxymethyl)-1,4-butanediyl)bis(3,4-dimethoxy-
phyllanthin [usp-rs]
CHEBI:8177 ,
A1-06840
4-[(2s,3s)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-1,2-dimethoxy-benzene
phyllanthin, analytical standard
phyllanthin, united states pharmacopeia (usp) reference standard
3,3',4,4',9,9'-hexamethoxylignan
tetra-o-methylsecoisolariciresinol
phyllanthin (usp-rs)
phyllanthin (constituent of phyllanthus amarus)
AKOS032948449
Q27107847
HY-N4107
CS-0032115
MS-27324
DTXSID001319088

Research Excerpts

Overview

Phyllanthin is a major bioactive lignan component of Phyllanthus amarus. It could passively diffuse through the absorptive barrier via transcellular pathway.

ExcerptReferenceRelevance
"Phyllanthin is a highly permeable compound that could passively diffuse through the absorptive barrier via transcellular pathway with little hindrance from P-gp. "( Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier.
Dunkoksung, W; Jianmongkol, S; Vardhanabhuti, N, 2019
)
2.2
"Phyllanthin is a major bioactive lignan component of Phyllanthus amarus, with several known biological activities. "( Physicochemical characterization of phyllanthin from Phyllanthus amarus Schum. et Thonn.
Hanh, ND; Mitrevej, A; Sinchaipanid, N, 2014
)
2.12

Bioavailability

In-vitro dissolution and oral bioavailability in rats of phy-SMEDDS were studied. Phyllanthin along with piperine was formulated as a mixed micellar lipid formulation (MMLF)

ExcerptReferenceRelevance
" In-vitro dissolution and oral bioavailability in rats of phy-SMEDDS were studied and compared with those of plain phyllanthin."( Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement.
Duc Hanh, N; Mitrevej, A; Peungvicha, P; Sathirakul, K; Sinchaipanid, N, 2015
)
0.98
" Phyllanthin along with piperine (a nutraceutical bioenhancer) was formulated as a mixed micellar lipid formulation (MMLF) in the present study and investigated to resolve the low bioavailability and enhance hepatoprotective effects on oral administration."( Antioxidant and hepatoprotective effects of mixed micellar lipid formulation of phyllanthin and piperine in carbon tetrachloride-induced liver injury in rodents.
Mishra, SH; Nagar, PA; Rajpara, A; Sethiya, NK; Shah, P, 2015
)
1.55

Dosage Studied

ExcerptRelevanceReference
" The findings could be useful tools for the development of stable and bioavailable oral dosage forms of phyllanthin."( Physicochemical characterization of phyllanthin from Phyllanthus amarus Schum. et Thonn.
Hanh, ND; Mitrevej, A; Sinchaipanid, N, 2014
)
0.89
" It can be further studied for optimum dosage to be used as a future of anti-anxiety drug development or as a standardized Phytomedicine."( An Insight Into the Anxiolytic Effects of Lignans (Phyllanthin and Hypophyllanthin) and Tannin (Corilagin) Rich Extracts of
Chopade, AR; Dharanguttikar, VR; Dias, RJ; Mali, SN; Naikwade, NS; Patil, PA; Pol, RP, 2021
)
0.87
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
lignanAny phenylpropanoid derived from phenylalanine via dimerization of substituted cinnamic alcohols, known as monolignols, to a dibenzylbutane skeleton. Note that while individual members of the class have names ending ...lignane, ...lignene, ...lignadiene, etc., the class names lignan, neolignan, etc., do not end with an "e".
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.70)18.7374
1990's0 (0.00)18.2507
2000's3 (8.11)29.6817
2010's24 (64.86)24.3611
2020's9 (24.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.68 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index5.32 (4.65)
Search Engine Demand Index45.47 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other37 (94.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]